Astria Therapeutics, Inc. (ATXS)
12.72
-0.16
(-1.24%)
USD |
NASDAQ |
Jan 12, 16:00
12.74
+0.02
(+0.16%)
After-Hours: 20:00
Astria Therapeutics Research and Development Expense (Quarterly): 24.15M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 44.27M |
| Hologic, Inc. | 65.10M |
| Johnson & Johnson | 3.693B |
| Alnylam Pharmaceuticals, Inc. | 358.81M |
| CorMedix, Inc. | 5.098M |